In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.

Amplification and increased expression of many growth factor receptors, including the epidermal growth factor receptor (EGFR), has been observed in human tumours. One therapeutic strategy for overcoming EGF autocrine control of tumour growth is inhibition of EGFR protein tyrosine kinase (PTK). A ser...

Descripción completa

Detalles Bibliográficos
Autores principales: McLeod, H. L., Brunton, V. G., Eckardt, N., Lear, M. J., Robins, D. J., Workman, P., Graham, M. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077212/
https://www.ncbi.nlm.nih.gov/pubmed/8956783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077212/
https://www.ncbi.nlm.nih.gov/pubmed/8956783

Ejemplares similares